1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acute Kidney Injury Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Non-drug 1.2.3 Drugs 1.3 Market by Application 1.3.1 Global Acute Kidney Injury Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Acute Kidney Injury Therapeutics Market Perspective (2016-2027) 2.2 Acute Kidney Injury Therapeutics Growth Trends by Regions 2.2.1 Acute Kidney Injury Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Acute Kidney Injury Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Acute Kidney Injury Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Acute Kidney Injury Therapeutics Industry Dynamic 2.3.1 Acute Kidney Injury Therapeutics Market Trends 2.3.2 Acute Kidney Injury Therapeutics Market Drivers 2.3.3 Acute Kidney Injury Therapeutics Market Challenges 2.3.4 Acute Kidney Injury Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Acute Kidney Injury Therapeutics Players by Revenue 3.1.1 Global Top Acute Kidney Injury Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Acute Kidney Injury Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Acute Kidney Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Acute Kidney Injury Therapeutics Revenue 3.4 Global Acute Kidney Injury Therapeutics Market Concentration Ratio 3.4.1 Global Acute Kidney Injury Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Acute Kidney Injury Therapeutics Revenue in 2020 3.5 Acute Kidney Injury Therapeutics Key Players Head office and Area Served 3.6 Key Players Acute Kidney Injury Therapeutics Product Solution and Service 3.7 Date of Enter into Acute Kidney Injury Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Acute Kidney Injury Therapeutics Breakdown Data by Type 4.1 Global Acute Kidney Injury Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Acute Kidney Injury Therapeutics Forecasted Market Size by Type (2022-2027) 5 Acute Kidney Injury Therapeutics Breakdown Data by Application 5.1 Global Acute Kidney Injury Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Acute Kidney Injury Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Acute Kidney Injury Therapeutics Market Size (2016-2027) 6.2 North America Acute Kidney Injury Therapeutics Market Size by Type 6.2.1 North America Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Acute Kidney Injury Therapeutics Market Size by Type (2016-2027) 6.3 North America Acute Kidney Injury Therapeutics Market Size by Application 6.3.1 North America Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Acute Kidney Injury Therapeutics Market Size by Application (2016-2027) 6.4 North America Acute Kidney Injury Therapeutics Market Size by Country 6.4.1 North America Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Acute Kidney Injury Therapeutics Market Size (2016-2027) 7.2 Europe Acute Kidney Injury Therapeutics Market Size by Type 7.2.1 Europe Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Acute Kidney Injury Therapeutics Market Size by Type (2016-2027) 7.3 Europe Acute Kidney Injury Therapeutics Market Size by Application 7.3.1 Europe Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Acute Kidney Injury Therapeutics Market Size by Application (2016-2027) 7.4 Europe Acute Kidney Injury Therapeutics Market Size by Country 7.4.1 Europe Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type 8.2.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application 8.3.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region 8.4.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Acute Kidney Injury Therapeutics Market Size (2016-2027) 9.2 Latin America Acute Kidney Injury Therapeutics Market Size by Type 9.2.1 Latin America Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Acute Kidney Injury Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Acute Kidney Injury Therapeutics Market Size by Application 9.3.1 Latin America Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Acute Kidney Injury Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Acute Kidney Injury Therapeutics Market Size by Country 9.4.1 Latin America Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type 10.2.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application 10.3.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country 10.4.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Quark Pharmaceuticals 11.1.1 Quark Pharmaceuticals Company Details 11.1.2 Quark Pharmaceuticals Business Overview 11.1.3 Quark Pharmaceuticals Acute Kidney Injury Therapeutics Introduction 11.1.4 Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.1.5 Quark Pharmaceuticals Recent Development 11.2 Alloksys 11.2.1 Alloksys Company Details 11.2.2 Alloksys Business Overview 11.2.3 Alloksys Acute Kidney Injury Therapeutics Introduction 11.2.4 Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.2.5 Alloksys Recent Development 11.3 Angio Biomedica Corporation 11.3.1 Angio Biomedica Corporation Company Details 11.3.2 Angio Biomedica Corporation Business Overview 11.3.3 Angio Biomedica Corporation Acute Kidney Injury Therapeutics Introduction 11.3.4 Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.3.5 Angio Biomedica Corporation Recent Development 11.4 Stealth Bio Therapeutics 11.4.1 Stealth Bio Therapeutics Company Details 11.4.2 Stealth Bio Therapeutics Business Overview 11.4.3 Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Introduction 11.4.4 Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.4.5 Stealth Bio Therapeutics Recent Development 11.5 Silver Creek Pharmaceuticals 11.5.1 Silver Creek Pharmaceuticals Company Details 11.5.2 Silver Creek Pharmaceuticals Business Overview 11.5.3 Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Introduction 11.5.4 Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.5.5 Silver Creek Pharmaceuticals Recent Development 11.6 AM Pharma Holding 11.6.1 AM Pharma Holding Company Details 11.6.2 AM Pharma Holding Business Overview 11.6.3 AM Pharma Holding Acute Kidney Injury Therapeutics Introduction 11.6.4 AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.6.5 AM Pharma Holding Recent Development 11.7 Ischemix 11.7.1 Ischemix Company Details 11.7.2 Ischemix Business Overview 11.7.3 Ischemix Acute Kidney Injury Therapeutics Introduction 11.7.4 Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.7.5 Ischemix Recent Development 11.8 Biomerieux 11.8.1 Biomerieux Company Details 11.8.2 Biomerieux Business Overview 11.8.3 Biomerieux Acute Kidney Injury Therapeutics Introduction 11.8.4 Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.8.5 Biomerieux Recent Development 11.9 A1M Pharma 11.9.1 A1M Pharma Company Details 11.9.2 A1M Pharma Business Overview 11.9.3 A1M Pharma Acute Kidney Injury Therapeutics Introduction 11.9.4 A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) 11.9.5 A1M Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Acute Kidney Injury Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Non-drug Table 3. Key Players of Drugs Table 4. Global Acute Kidney Injury Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Acute Kidney Injury Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Acute Kidney Injury Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Acute Kidney Injury Therapeutics Market Share by Regions (2016-2021) Table 8. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Acute Kidney Injury Therapeutics Market Share by Regions (2022-2027) Table 10. Acute Kidney Injury Therapeutics Market Trends Table 11. Acute Kidney Injury Therapeutics Market Drivers Table 12. Acute Kidney Injury Therapeutics Market Challenges Table 13. Acute Kidney Injury Therapeutics Market Restraints Table 14. Global Acute Kidney Injury Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Acute Kidney Injury Therapeutics Market Share by Players (2016-2021) Table 16. Global Top Acute Kidney Injury Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Kidney Injury Therapeutics as of 2020) Table 17. Ranking of Global Top Acute Kidney Injury Therapeutics Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Acute Kidney Injury Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Acute Kidney Injury Therapeutics Product Solution and Service Table 21. Date of Enter into Acute Kidney Injury Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 24. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2016-2021) Table 25. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Acute Kidney Injury Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Acute Kidney Injury Therapeutics Revenue Market Share by Application (2016-2021) Table 29. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Acute Kidney Injury Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 32. North America Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 34. North America Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 61. Quark Pharmaceuticals Company Details Table 62. Quark Pharmaceuticals Business Overview Table 63. Quark Pharmaceuticals Acute Kidney Injury Therapeutics Product Table 64. Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 65. Quark Pharmaceuticals Recent Development Table 66. Alloksys Company Details Table 67. Alloksys Business Overview Table 68. Alloksys Acute Kidney Injury Therapeutics Product Table 69. Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 70. Alloksys Recent Development Table 71. Angio Biomedica Corporation Company Details Table 72. Angio Biomedica Corporation Business Overview Table 73. Angio Biomedica Corporation Acute Kidney Injury Therapeutics Product Table 74. Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 75. Angio Biomedica Corporation Recent Development Table 76. Stealth Bio Therapeutics Company Details Table 77. Stealth Bio Therapeutics Business Overview Table 78. Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Product Table 79. Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 80. Stealth Bio Therapeutics Recent Development Table 81. Silver Creek Pharmaceuticals Company Details Table 82. Silver Creek Pharmaceuticals Business Overview Table 83. Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Product Table 84. Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 85. Silver Creek Pharmaceuticals Recent Development Table 86. AM Pharma Holding Company Details Table 87. AM Pharma Holding Business Overview Table 88. AM Pharma Holding Acute Kidney Injury Therapeutics Product Table 89. AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 90. AM Pharma Holding Recent Development Table 91. Ischemix Company Details Table 92. Ischemix Business Overview Table 93. Ischemix Acute Kidney Injury Therapeutics Product Table 94. Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 95. Ischemix Recent Development Table 96. Biomerieux Company Details Table 97. Biomerieux Business Overview Table 98. Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 99. Biomerieux Recent Development Table 100. A1M Pharma Company Details Table 101. A1M Pharma Business Overview Table 102. A1M Pharma Acute Kidney Injury Therapeutics Product Table 103. A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million) Table 104. A1M Pharma Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Acute Kidney Injury Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Non-drug Features Figure 3. Drugs Features Figure 4. Global Acute Kidney Injury Therapeutics Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. Acute Kidney Injury Therapeutics Report Years Considered Figure 9. Global Acute Kidney Injury Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Acute Kidney Injury Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Acute Kidney Injury Therapeutics Market Share by Regions: 2020 VS 2027 Figure 12. Global Acute Kidney Injury Therapeutics Market Share by Regions (2022-2027) Figure 13. Global Acute Kidney Injury Therapeutics Market Share by Players in 2020 Figure 14. Global Top Acute Kidney Injury Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Kidney Injury Therapeutics as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Acute Kidney Injury Therapeutics Revenue in 2020 Figure 16. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2016-2021) Figure 17. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2022-2027) Figure 18. North America Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Acute Kidney Injury Therapeutics Market Share by Type (2016-2027) Figure 20. North America Acute Kidney Injury Therapeutics Market Share by Application (2016-2027) Figure 21. North America Acute Kidney Injury Therapeutics Market Share by Country (2016-2027) Figure 22. United States Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Acute Kidney Injury Therapeutics Market Share by Type (2016-2027) Figure 26. Europe Acute Kidney Injury Therapeutics Market Share by Application (2016-2027) Figure 27. Europe Acute Kidney Injury Therapeutics Market Share by Country (2016-2027) Figure 28. Germany Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Acute Kidney Injury Therapeutics Market Share by Type (2016-2027) Figure 36. Asia-Pacific Acute Kidney Injury Therapeutics Market Share by Application (2016-2027) Figure 37. Asia-Pacific Acute Kidney Injury Therapeutics Market Share by Region (2016-2027) Figure 38. China Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Acute Kidney Injury Therapeutics Market Share by Type (2016-2027) Figure 46. Latin America Acute Kidney Injury Therapeutics Market Share by Application (2016-2027) Figure 47. Latin America Acute Kidney Injury Therapeutics Market Share by Country (2016-2027) Figure 48. Mexico Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Acute Kidney Injury Therapeutics Market Share by Type (2016-2027) Figure 52. Middle East & Africa Acute Kidney Injury Therapeutics Market Share by Application (2016-2027) Figure 53. Middle East & Africa Acute Kidney Injury Therapeutics Market Share by Country (2016-2027) Figure 54. Turkey Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Quark Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 58. Alloksys Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 59. Angio Biomedica Corporation Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 60. Stealth Bio Therapeutics Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 61. Silver Creek Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 62. AM Pharma Holding Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 63. Ischemix Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 64. Biomerieux Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 65. A1M Pharma Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Quark Pharmaceuticals Alloksys Angio Biomedica Corporation Stealth Bio Therapeutics Silver Creek Pharmaceuticals AM Pharma Holding Ischemix Biomerieux A1M Pharma